Alembic receives tentative OK from FDA for generic UptraviSelexipag is indicated for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization. Hikma launches sodium acetate injection Sodium acetate injection had a market value of roughly $26 million in the 12 months ending May 2024, per IQVIA. Amneal intros Focinvez Focinvez 150 mg/50 mL single dose vial is an anti-nausea agent for emetogenic chemotherapy. Arunesh Verma joins Fresenius Kabi USA as president Verma succeeds John Ducker who will retire after 35 years with the company. Fresenius debuts subcutaneous formulation of biosimilar Tyenne Tyenne is an FDA-approved tocilizumab biosimilar that is available in both intravenous and subcutaneous formulations. Yaral Pharma becomes exclusive supplier of authorized generic levothyroxine sodium capsules Levothyroxine Sodium Capsules are used to treat hypothyroidism. FDA gives Lupin tentative approval for generic Trijardy Trijardy contains three diabetes medications: empagliflozin, linagliptin and metformin hydrochloride. FDA approves Jiangsu Hengrui’s generic Exparel The FDA has approved bupivacaine liposome, which is a generic of Pacira BioScience's Exparel. FTC releases interim staff report on prescription drug middlemen The interim staff report details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States. American Regent releases sodium phosphates injection Sodium phosphates injection is indicated to prevent hypophosphatemia in patients with restricted or no oral intake. First Previous 23 24 25 26 27 Next Last
